Bobby Eisenberg has worked with El Dorado officials to develop regulations that recognize a patient’s right to grow as much cannabis as their doctor authorizes. Now the planning commission in El Dorado Country wants to impose a six-plant limit.
What would we envision as the best cannabis model for international patient access? This question was explored at a collaborative event in Barcelona just before the COVID-19 lockdowns swept over Spain (and the world).
Joe D. Goldstrich, MD, FACC outlines what we know about the antiviral properties of cannabis and whether or not it could be helpful or detrimental for COVID-19.
Sarah Mann, MD separates myth and conjecture from what is known (and unknown) about cannabis and sex.
This review paper by Dr. Robert Silver gives an overview of the ECS in animals and highlights it as a topic of interest for emerging therapeutics.
Does cannabis have synergy with other plants? James Brent, DDS reviews the literature.
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.
A long-term observational stud found cannabis worked as an alternative to prescription opioids in over half of patients with low back pain and an be an adjunct therap to diminish chronic opioid use for some people.
Dr. Patricia Frye summarizes a cannabis policy hearing at the House of Representatives. Dr. Frye saw strong bipartisan support for decreasing the barriers to research on cannabis medicine.
The SCC sent a poll to its membership to gauge how those within the organization were approaching the pen pen issue and EVALI. Learn more about their recommendations and considerations.
The IACM conference in Berlin highlighted talks from the top professionals in the field of cannabis science. Christine Milentis, our Executive Secretary, reports on the history of cannabis for medical use and the rights of doctors across the globe to prescribe it.